CAMBRIDGE, Mass.--(BUSINESS WIRE)--Effective today, Biogen Idec is known simply as Biogen (NASDAQ: BIIB). The company has introduced a new corporate identity and logo that reflect both its ...

Biogen Inc has finalized a $900 million settlement resolving a whistleblower lawsuit accusing the biotech company of paying doctors kickbacks to prescribe multiple sclerosis drugs, the U.S ...

Biogen said on Wednesday it had agreed to buy privately held Human Immunology Biosciences for up to $1.8 billion, ... Biogen logo is seen displayed in this illustration taken, May 3, 2022.

Biogen Head of R&D Alfred Sandrock, Jr., M.D., Ph.D., said, "Through this collaboration, we aim to solve key technological challenges in the delivery of gene therapies to target tissues.